BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38256138)

  • 21. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
    Thakker RV; Newey PJ; Walls GV; Bilezikian J; Dralle H; Ebeling PR; Melmed S; Sakurai A; Tonelli F; Brandi ML;
    J Clin Endocrinol Metab; 2012 Sep; 97(9):2990-3011. PubMed ID: 22723327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
    Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
    Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
    Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
    Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
    Giusti F; Cianferotti L; Boaretto F; Cetani F; Cioppi F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Fossi C; Giudici F; Gronchi G; Loli P; Mantero F; Marcocci C; Marini F; Masi L; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Sciortino G; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2017 Nov; 58(2):349-359. PubMed ID: 28132167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Indian family of multiple endocrine neoplasia type 1 (MEN1): molecular diagnosis, treatment and follow up.
    Shah SR; Raghavan R; Desai DC; Chauhan PH; Lala M; Dherai AJ; Ashavaid TF
    Indian J Gastroenterol; 2008; 27(6):242-4. PubMed ID: 19405259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary tumors in patients with MEN1 syndrome.
    Syro LV; Scheithauer BW; Kovacs K; Toledo RA; Londoño FJ; Ortiz LD; Rotondo F; Horvath E; Uribe H
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):43-8. PubMed ID: 22584705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
    Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
    Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene.
    Griniatsos JE; Dimitriou N; Zilos A; Sakellariou S; Evangelou K; Kamakari S; Korkolopoulou P; Kaltsas G
    World J Surg Oncol; 2011 Jan; 9():6. PubMed ID: 21266030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare clinical manifestation of multiple endocrine neoplasia type 1.
    Petriczko E; Marcinkiewicz K; Prokurat A; Sagan L; Malkowski B; Biczysko-Mokosa A; Horodnicka-Jozwa A; Andrysiak-Mamos E; Syrenicz A; Kostrzeba E; Walczak M
    Neuro Endocrinol Lett; 2022 Nov; 43(4):199-207. PubMed ID: 36528881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
    Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
    Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
    Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
    J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1.
    Lourenço DM; Toledo RA; Coutinho FL; Margarido LC; Siqueira SA; dos Santos MA; Montenegro FL; Machado MC; Toledo SP
    Clinics (Sao Paulo); 2007 Aug; 62(4):465-76. PubMed ID: 17823710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
    Giraud S; Zhang CX; Serova-Sinilnikova O; Wautot V; Salandre J; Buisson N; Waterlot C; Bauters C; Porchet N; Aubert JP; Emy P; Cadiot G; Delemer B; Chabre O; Niccoli P; Leprat F; Duron F; Emperauger B; Cougard P; Goudet P; Sarfati E; Riou JP; Guichard S; Rodier M; Meyrier A; Caron P; Vantyghem MC; Assayag M; Peix JL; Pugeat M; Rohmer V; Vallotton M; Lenoir G; Gaudray P; Proye C; Conte-Devolx B; Chanson P; Shugart YY; Goldgar D; Murat A; Calender A
    Am J Hum Genet; 1998 Aug; 63(2):455-67. PubMed ID: 9683585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multiple endocrine neoplasia type I].
    Kawa S; Karasawa Y; Oguchi H; Furuta S
    Nihon Rinsho; 1995 Nov; 53(11):2702-7. PubMed ID: 8538030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
    Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
    Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene diagnosis and clinical management of multiple endocrine neoplasia type 1 (MEN1).
    Hai N; Kosugi S
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():47s-51s. PubMed ID: 10914990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.